Défimédoc

What Défimédoc does

Défimédoc SAS is a French privately-held company founded in 2019 that operates a mobile-first continuing education service for healthcare professionals, with its primary target being French community pharmacists (pharmaciens d'officine, both titulaires and adjoints). Its core product is a subscription-based iOS and Android application that delivers two new formative quizzes per week covering medication classes, therapeutic molecules, prescription drugs, pathologies, and health-related news, paired with 10-point synthesis fiches ("Fiches L'Essentiel") sourced from official French health authorities (HAS, ANSM, medicaments.gouv.fr). A six-member scientific committee chaired by founder and President Florence Bontemps — formerly Scientific Director of Le Moniteur des Pharmacies for 10 years — authors and validates content, and contributors write for external pharmacy publications (Le Moniteur des Pharmacies, Le Quotidien du Pharmacien, VIDAL.fr, Pharmaradio, Porphyre), reinforcing the company's domain authority.

The business model combines a self-serve individual subscription (€11.99 TTC/month or €107.99 TTC/year with a 14-day free trial) with team/group licensing sold through pharmacy groupements, unions, and student associations including Giropharm, FSPF, USPO, Giphar, Capunipharm, Ceido, and ANEPF. Since April 2024 the annual 100-quiz parcours has been labelled by the Conseil National de Pharmacie (CNP) as a recognized DPC (Développement Professionnel Continu) training action for community pharmacists, requiring 60% quiz validation at a minimum 70/100 score; the company also holds Qualiopi certification from Bureau Veritas. Secondary personas served include hospital pharmacists, physicians, pharmacy students, and pharmacy technicians, though CNP labellisation only extends to officinal pharmacists.

The application includes gamified score tracking, badges, leaderboards, and discussion forums tied to each quiz, plus statistical dashboards comparing learner progress against peers. In 2024, 90% of participants validated their DPC training, the average satisfaction score reached 9.1/10, and 80% of participants indicated intent to repeat training with Défimédoc. The company operates from Angers, France with a 5-person team, and in 2024 announced a strategic rapprochement with Ma Formation Officinale to jointly expand pharmacy training and innovation offerings. No external funding, acquisitions, or revenue figures have been disclosed, and registered share capital stands at €5,000.

Name

Défimédoc

Legal name

Défimédoc

Website

https://defimedoc.fr

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

Défimédoc is a French mobile application that delivers quiz-based continuing education on medications to community pharmacists, hospital pharmacists, physicians, pharmacy students, and technicians. It monetizes via individual subscriptions and groupement-led team licensing, with a CNP-labelled DPC certification pathway.

Ownership category

akta.pro rank

Product category

Healthcare Professional Education / Continuing Medical Education

SIC

Services-Prepackaged Software (7372), Services-Misc Health & Allied Services, Nec (8090)

akta.pro primary industry

Medication Adherence, Packaging & Fulfillment Services (Blister/Unit-Dose) (HLAFALAJ)

Keywords

• Pharmacy continuing education
• Medication training app
• DPC certification training
• Gamified medical quizzes
• Pharmaceutical professional development

Headquarters

HQ city

Angers

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

1. Individual Subscription (Solo): Monthly or annual subscription for individual healthcare professionals. Monthly: 11.99€ TTC/month. Annual: 107.99€ TTC/year (approximately 9€ per month equivalent). Includes 14-day free trial.
2. Team/Group Subscription: Subscription for pharmacy teams through groupements (Giropharm, FSPF, USPO, etc.). Pricing negotiated per partnership agreement.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

Défimédoc is a mobile application (iOS and Android) for healthcare professionals — primarily community pharmacists — to maintain and update their knowledge of medications through gamified formative quizzes published twice weekly, 10-point synthesis fiches, performance statistics, and peer discussion forums. The company sells individual monthly (€11.99) and annual (€107.99) subscriptions with a 14-day free trial, plus team/group licensing through pharmacy groupements.

Product overview

Défimédoc is a single mobile application providing quiz-based pharmaceutical training for healthcare professionals. The core offering consists of the Défimédoc mobile app with four integrated modules: Quiz (formative assessments published twice weekly), Fiches L'Essentiel (10-point medication summary sheets), Scores (performance tracking with badges and leaderboards), and Discussions (peer-to-peer topic exchanges). An optional add-on is the DPC Training Program (labellised by CNP Pharmacie) which provides a structured 100-quiz annual curriculum validating continuing education requirements for French community pharmacists. The application is available via subscription (monthly at €11.99/month or annual at €107.99/year) with a 14-day free trial.

Differentiator

Problem solved

Functional benefit

Products and services

• Défimédoc Mobile Application A mobile application (iOS and Android) for healthcare professionals — primarily community pharmacists — to maintain and update their knowledge on medications through gamified quizzes published twice weekly, 10-point synthesis fiches, performance statistics, and peer discussion forums. Available via individual monthly (€11.99) or annual (€107.99) subscription with a 14-day free trial.
• Parcours DPC Défimédoc (CNP-labelled) A CNP Pharmacie-labelled continuing professional development (DPC) program consisting of 100 quizzes to be completed over one year (with minimum 60% validated at score 70/100), providing French community pharmacists with regulatory-recognized DPC certification. Available as a one-year subscription (individual or team).

Quantifiable outcome

• 90% of participants validated their DPC training in 2024
• +2 more outcomes

Named customers19 records

Segments5 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Seven partnerships are on record, tiered core and minor.

• Ma Formation OfficinalecoreStrategic or Co-development PartnerStrategic partnership/merger announced to expand reach in the pharmacy training sector. Florence Bontemps, Présidente of Défimédoc, referenced the rapprochement as responding to growing sector needs for training and innovation. Combined offerings provide exclusive discounts on licenses.
• GiropharmcoreChannel Partner/ Reseller/ DistributorMajor pharmacy network/groupement offering Défimédoc team licenses to member pharmacies. Listed as a trusted partner.
• FSPF (Fédération des Syndicats Pharmaceutiques de France)coreChannel Partner/ Reseller/ DistributorMajor pharmacy union federation offering Défimédoc to member pharmacies. Listed as a trusted partner.
• USPO (Union des Syndicats de Pharmaciens d'Officine)coreChannel Partner/ Reseller/ DistributorMajor pharmacy union representing pharmacy owners. Offering Défimédoc team licenses to member pharmacies.
• GipharcoreChannel Partner/ Reseller/ DistributorPharmacy network/groupement offering Défimédoc to member pharmacies. Listed as a trusted partner.
• Pharm-uppminorChannel Partner/ Reseller/ DistributorPharmacy services provider. Listed as a trusted partner.
• ANEPF (Association Nationale des Étudiants en Pharmacie de France)minorChannel Partner/ Reseller/ DistributorNational pharmacy student association. Listed as a trusted partner offering access to pharmacy students.

Scale indicators6 records

Recent moves7 records

Expansion highlights6 records

Broad incumbents

• Wolters Kluwer Health: Multinational publisher of medical, nursing, and pharmacy learning solutions including Lippincott and clinical drug information products. Comparable as a broad incumbent whose pharmacy and clinician education offerings overlap with Défimédoc's.
• Elsevier Clinical Solutions: Global medical information and clinical decision support provider that owns pharmacy-relevant brands and serves as a broad incumbent in clinical education. Comparable as a much larger player offering overlapping pharmacist and clinician learning content.

Emerging players

• Doximity: US-based clinician network and continuing medical education platform with mobile-first learning modules. Comparable as an emerging digital-health education platform targeting healthcare professionals with subscription-based mobile CME.

Direct peers

• Ma Formation Officinale: French pharmacy continuing education provider that announced a 2024 partnership/rapprochement with Défimédoc. Directly comparable as a competing pharmacy training platform now operating in a strategic alliance with the subject company.
• VIDAL: France's leading drug information reference used by pharmacists and physicians, providing medication monographs, interaction checking, and continuing education content. Directly comparable as a foundational medication knowledge resource for French pharmacy professionals.
• Le Moniteur des Pharmacies: Long-established French pharmacy publication and training provider offering DPC e-learning modules and Cahiers Formation. It is the most directly comparable competitor and is also the company where founder Florence Bontemps served as Scientific Director for 10 years.

Regional players

• Pharmagora: Major French pharmacy trade event and education platform that awarded Défimédoc its 2024 Innovation Prize. Comparable as a regional French ecosystem player in pharmacy professional training and event-based education.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/defimedoc

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Défimédoc